US Stock MarketDetailed Quotes

CXRXF ADVANZ PHARMA CO

Watchlist
  • 0.000
  • 0.0000.00%
15min DelayTrading Apr 29 09:30 ET
0Market Cap0.00P/E (TTM)

ADVANZ PHARMA CO Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2019
(Q4)Dec 31, 2019
(Q3)Sep 30, 2019
(Q2)Jun 30, 2019
(Q1)Mar 31, 2019
(FY)Dec 31, 2018
(Q4)Dec 31, 2018
(Q3)Sep 30, 2018
(Q2)Jun 30, 2018
(Q1)Mar 31, 2018
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
32.88%188.18M
-14.30%37.32M
278.43%53.44M
54.14%51.47M
-9.11%45.95M
-49.99%141.62M
-21.87%43.55M
-80.35%14.12M
-51.86%33.39M
-41.35%50.56M
Net income from continuing operations
-113.36%-196.02M
71.03%-24.6M
-106.67%-119.18M
75.41%-44.26M
85.66%-7.99M
192.24%1.47B
80.33%-84.93M
2,673.05%1.79B
82.19%-179.95M
29.34%-55.69M
Operating gains losses
98.70%-24.68M
-503.66%-10.89M
99.38%-11.93M
-85.26%10.4M
70.10%-12.26M
-12,315.80%-1.89B
-119.54%-1.8M
-130,424.39%-1.92B
811.99%70.56M
-329.84%-41.01M
Depreciation and amortization
-18.07%206.55M
-23.29%46.19M
-14.94%52.41M
-15.81%54.05M
-18.43%53.9M
10.38%252.1M
16.60%60.21M
19.46%61.61M
-5.54%64.21M
15.51%66.08M
Deferred tax
-1,628.26%-22.01M
-664.39%-14.66M
-193.71%-6.14M
83.94%-1.27M
-98.60%66K
103.92%1.44M
75.42%-1.92M
79.05%6.56M
78.71%-7.9M
4.79%4.7M
Other non cash items
-59.08%104.31M
-2.02%24.65M
-65.25%26.05M
-64.01%26.99M
-66.65%26.63M
-41.94%254.92M
-88.47%25.15M
-2.27%74.96M
-2.22%74.97M
18.60%79.84M
Change In working capital
-34.76%11.77M
461.14%5.14M
-5.80%8.94M
48.11%8.37M
-642.04%-10.69M
-57.51%18.03M
-91.56%916K
-29.90%9.49M
123.39%5.65M
-87.29%1.97M
-Change in receivables
-85.34%4.92M
-53.00%9.59M
161.53%5.7M
-84.67%2.12M
-339.43%-12.49M
13.53%33.54M
112.32%20.41M
-70.27%2.18M
336.71%13.8M
-115.43%-2.84M
-Change in inventory
0.82%3.19M
-5.70%-9.19M
35.59%3.09M
-45.18%1.51M
14.03%7.79M
-79.48%3.17M
-262.63%-8.7M
-32.68%2.28M
-50.30%2.76M
488.79%6.83M
-Change in prepaid assets
127.95%2.32M
-454.90%-6.35M
104.35%187K
694.78%7.07M
185.02%1.41M
-945.36%-8.29M
-84.22%-1.14M
-422.99%-4.3M
32.42%-1.19M
-181.91%-1.66M
-Change in payables and accrued expense
839.65%6.99M
347.95%15.29M
-142.68%-3.74M
-19.73%-3.67M
-173.88%-894K
107.85%744K
-97.22%-6.17M
378.19%8.76M
-431.03%-3.06M
129.29%1.21M
-Change in other working capital
49.20%-5.65M
-20.61%-4.2M
548.69%3.7M
120.23%1.35M
-316.06%-6.5M
-286.79%-11.13M
-867.50%-3.48M
-87.70%571K
-282.55%-6.65M
20.66%-1.56M
Cash from discontinued investing activities
Operating cash flow
32.88%188.18M
-14.30%37.32M
278.43%53.44M
54.14%51.47M
-9.11%45.95M
-49.99%141.62M
-21.87%43.55M
-80.35%14.12M
-51.86%33.39M
-41.35%50.56M
Investing cash flow
Cash flow from continuing investing activities
-1,634.90%-34.25M
-388.07%-2.92M
93.95%-75K
-18,512.73%-30.71M
65.89%-540K
-267.60%-1.97M
714.55%1.01M
-829.41%-1.24M
26.67%-165K
-399.37%-1.58M
Capital expenditure reported
-39.55%-5.77M
10,936.99%26.66M
67.63%-506K
-6,533.33%-31.04M
52.58%-882K
-67.56%-4.14M
80.95%-246K
-414.14%-1.56M
-20.00%-468K
---1.86M
Net business purchase and sale
---30M
----
----
----
----
--0
----
----
----
----
Net other investing changes
-99.26%7K
--0
--0
--0
133.33%7K
-14.89%943K
-11.52%929K
--7K
--4K
--3K
Cash from discontinued investing activities
Investing cash flow
-1,634.90%-34.25M
-388.07%-2.92M
93.95%-75K
-18,512.73%-30.71M
65.89%-540K
-267.60%-1.97M
714.55%1.01M
-829.41%-1.24M
26.67%-165K
-399.37%-1.58M
Financing cash flow
Cash flow from continuing financing activities
42.17%-129.93M
-64.66%-39.73M
57.89%-25.46M
60.95%-39.53M
35.10%-25.22M
39.67%-224.68M
66.28%-24.13M
-51.97%-60.45M
7.57%-101.24M
74.35%-38.86M
Net issuance payments of debt
96.43%-22.57M
-30.41%-6.84M
99.14%-5.22M
52.09%-5.26M
53.49%-5.25M
-1,004.11%-632.43M
78.58%-5.25M
-5,367.87%-604.91M
-0.42%-10.99M
-4.68%-11.28M
Net common stock issuance
--0
--0
----
----
----
--587.31M
--0
----
----
----
Cash dividends paid
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Net other financing activities
----
----
----
----
----
-119.65%-45.7M
--0
-268.38%-197K
----
----
Cash from discontinued financing activities
Financing cash flow
42.17%-129.93M
-64.66%-39.73M
57.89%-25.46M
60.95%-39.53M
35.10%-25.22M
39.67%-224.68M
66.28%-24.13M
-51.97%-60.45M
7.57%-101.24M
74.35%-38.86M
Net cash flow
Beginning cash position
-31.37%224.44M
16.18%243.34M
-13.57%224.31M
-27.70%248.59M
-31.37%224.44M
-17.81%327.03M
-38.63%209.46M
-14.00%259.53M
2.28%343.83M
-17.81%327.03M
Current changes in cash
128.22%24M
-126.07%-5.33M
158.66%27.91M
72.40%-18.77M
99.60%20.19M
5.27%-85.03M
227.88%20.44M
-247.57%-47.57M
-68.41%-68.01M
115.41%10.12M
Effect of exchange rate changes
172.34%12.7M
523.89%23.12M
-254.78%-8.87M
66.20%-5.51M
-40.79%3.96M
-193.06%-17.56M
-419.19%-5.46M
-134.34%-2.5M
-371.05%-16.29M
72.95%6.69M
End cash Position
16.35%261.14M
16.35%261.14M
16.18%243.34M
-13.57%224.31M
-27.70%248.59M
-31.37%224.44M
-31.37%224.44M
-38.63%209.46M
-14.00%259.53M
2.28%343.83M
Free cash flow
32.68%182.4M
47.75%63.98M
321.50%52.93M
-37.96%20.43M
-7.45%45.07M
-51.02%137.48M
-20.47%43.3M
-82.45%12.56M
-52.27%32.92M
-43.19%48.7M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2019(Q4)Dec 31, 2019(Q3)Sep 30, 2019(Q2)Jun 30, 2019(Q1)Mar 31, 2019(FY)Dec 31, 2018(Q4)Dec 31, 2018(Q3)Sep 30, 2018(Q2)Jun 30, 2018(Q1)Mar 31, 2018
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 32.88%188.18M-14.30%37.32M278.43%53.44M54.14%51.47M-9.11%45.95M-49.99%141.62M-21.87%43.55M-80.35%14.12M-51.86%33.39M-41.35%50.56M
Net income from continuing operations -113.36%-196.02M71.03%-24.6M-106.67%-119.18M75.41%-44.26M85.66%-7.99M192.24%1.47B80.33%-84.93M2,673.05%1.79B82.19%-179.95M29.34%-55.69M
Operating gains losses 98.70%-24.68M-503.66%-10.89M99.38%-11.93M-85.26%10.4M70.10%-12.26M-12,315.80%-1.89B-119.54%-1.8M-130,424.39%-1.92B811.99%70.56M-329.84%-41.01M
Depreciation and amortization -18.07%206.55M-23.29%46.19M-14.94%52.41M-15.81%54.05M-18.43%53.9M10.38%252.1M16.60%60.21M19.46%61.61M-5.54%64.21M15.51%66.08M
Deferred tax -1,628.26%-22.01M-664.39%-14.66M-193.71%-6.14M83.94%-1.27M-98.60%66K103.92%1.44M75.42%-1.92M79.05%6.56M78.71%-7.9M4.79%4.7M
Other non cash items -59.08%104.31M-2.02%24.65M-65.25%26.05M-64.01%26.99M-66.65%26.63M-41.94%254.92M-88.47%25.15M-2.27%74.96M-2.22%74.97M18.60%79.84M
Change In working capital -34.76%11.77M461.14%5.14M-5.80%8.94M48.11%8.37M-642.04%-10.69M-57.51%18.03M-91.56%916K-29.90%9.49M123.39%5.65M-87.29%1.97M
-Change in receivables -85.34%4.92M-53.00%9.59M161.53%5.7M-84.67%2.12M-339.43%-12.49M13.53%33.54M112.32%20.41M-70.27%2.18M336.71%13.8M-115.43%-2.84M
-Change in inventory 0.82%3.19M-5.70%-9.19M35.59%3.09M-45.18%1.51M14.03%7.79M-79.48%3.17M-262.63%-8.7M-32.68%2.28M-50.30%2.76M488.79%6.83M
-Change in prepaid assets 127.95%2.32M-454.90%-6.35M104.35%187K694.78%7.07M185.02%1.41M-945.36%-8.29M-84.22%-1.14M-422.99%-4.3M32.42%-1.19M-181.91%-1.66M
-Change in payables and accrued expense 839.65%6.99M347.95%15.29M-142.68%-3.74M-19.73%-3.67M-173.88%-894K107.85%744K-97.22%-6.17M378.19%8.76M-431.03%-3.06M129.29%1.21M
-Change in other working capital 49.20%-5.65M-20.61%-4.2M548.69%3.7M120.23%1.35M-316.06%-6.5M-286.79%-11.13M-867.50%-3.48M-87.70%571K-282.55%-6.65M20.66%-1.56M
Cash from discontinued investing activities
Operating cash flow 32.88%188.18M-14.30%37.32M278.43%53.44M54.14%51.47M-9.11%45.95M-49.99%141.62M-21.87%43.55M-80.35%14.12M-51.86%33.39M-41.35%50.56M
Investing cash flow
Cash flow from continuing investing activities -1,634.90%-34.25M-388.07%-2.92M93.95%-75K-18,512.73%-30.71M65.89%-540K-267.60%-1.97M714.55%1.01M-829.41%-1.24M26.67%-165K-399.37%-1.58M
Capital expenditure reported -39.55%-5.77M10,936.99%26.66M67.63%-506K-6,533.33%-31.04M52.58%-882K-67.56%-4.14M80.95%-246K-414.14%-1.56M-20.00%-468K---1.86M
Net business purchase and sale ---30M------------------0----------------
Net other investing changes -99.26%7K--0--0--0133.33%7K-14.89%943K-11.52%929K--7K--4K--3K
Cash from discontinued investing activities
Investing cash flow -1,634.90%-34.25M-388.07%-2.92M93.95%-75K-18,512.73%-30.71M65.89%-540K-267.60%-1.97M714.55%1.01M-829.41%-1.24M26.67%-165K-399.37%-1.58M
Financing cash flow
Cash flow from continuing financing activities 42.17%-129.93M-64.66%-39.73M57.89%-25.46M60.95%-39.53M35.10%-25.22M39.67%-224.68M66.28%-24.13M-51.97%-60.45M7.57%-101.24M74.35%-38.86M
Net issuance payments of debt 96.43%-22.57M-30.41%-6.84M99.14%-5.22M52.09%-5.26M53.49%-5.25M-1,004.11%-632.43M78.58%-5.25M-5,367.87%-604.91M-0.42%-10.99M-4.68%-11.28M
Net common stock issuance --0--0--------------587.31M--0------------
Cash dividends paid --0--0--0--0--0--0--0--0--0--0
Net other financing activities ---------------------119.65%-45.7M--0-268.38%-197K--------
Cash from discontinued financing activities
Financing cash flow 42.17%-129.93M-64.66%-39.73M57.89%-25.46M60.95%-39.53M35.10%-25.22M39.67%-224.68M66.28%-24.13M-51.97%-60.45M7.57%-101.24M74.35%-38.86M
Net cash flow
Beginning cash position -31.37%224.44M16.18%243.34M-13.57%224.31M-27.70%248.59M-31.37%224.44M-17.81%327.03M-38.63%209.46M-14.00%259.53M2.28%343.83M-17.81%327.03M
Current changes in cash 128.22%24M-126.07%-5.33M158.66%27.91M72.40%-18.77M99.60%20.19M5.27%-85.03M227.88%20.44M-247.57%-47.57M-68.41%-68.01M115.41%10.12M
Effect of exchange rate changes 172.34%12.7M523.89%23.12M-254.78%-8.87M66.20%-5.51M-40.79%3.96M-193.06%-17.56M-419.19%-5.46M-134.34%-2.5M-371.05%-16.29M72.95%6.69M
End cash Position 16.35%261.14M16.35%261.14M16.18%243.34M-13.57%224.31M-27.70%248.59M-31.37%224.44M-31.37%224.44M-38.63%209.46M-14.00%259.53M2.28%343.83M
Free cash flow 32.68%182.4M47.75%63.98M321.50%52.93M-37.96%20.43M-7.45%45.07M-51.02%137.48M-20.47%43.3M-82.45%12.56M-52.27%32.92M-43.19%48.7M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg